Home › Modalities › Cell

Cell (31 companies)

Ticker	Company	Therapeutic areas	Programs	Lead stage	Programs
ACET	Adicet Bio	ImmunologyNeurology+2 Rare	8	Phase 1	8
ALLO	Allogene Therapeutics	ImmunologyOncology Rare	10	Phase 2	10
ANIX	Anixa Biosciences	Oncology	1	Phase 1	3
ARTV	Artiva Biotherapeutics	DermatologyImmunology+2 Rare	14	Phase 2	14
AUTL	Autolus Therapeutics	HematologyImmunology+3 Rare	12	Approved	12
BEAM	Beam Therapeutics	HematologyMetabolic+1 Rare	1	Phase 2	6
BCTX	BriaCell Therapeutics	Oncology	6	Phase 3	7
CABA	Cabaletta Bio	DermatologyImmunology+2 Rare	8	Phase 1	8
CAPR	Capricor Therapeutics	Infectious DiseaseNeurology Rare	1	NDA Submitted	2
CRBU	Caribou Biosciences	Oncology	4	Phase 1	4
RNAC	Cartesian Therapeutics	ImmunologyNeurology+1 Rare	4	Phase 3	4
IPSC	Century Therapeutics	ImmunologyMetabolic+1 Rare	9	Phase 1	9
FBIO	Fortress Biotech	DermatologyHematology+2 Rare	1	Approved	12
IMTX	Immatics	Oncology	2	Phase 2	8
IMMX	Immix Biopharma	Hematology Rare	1	Phase 1	1
IBRX	ImmunityBio	Infectious DiseaseOncology	6	Approved	16
INAB	IN8bio	ImmunologyOncology	5	Phase 2	6
INMB	Inmune Bio	DermatologyOncology Rare	2	Phase 2	2
KAPA	Kairos Pharma	Oncology	1	Phase 2	9
KYTX	Kyverna Therapeutics	ImmunologyNeurology+1 Rare	7	NDA Submitted	7
LEGN	Legend Biotech	Oncology Rare	8	Approved	8
LCTX	Lineage Cell Therapeutics	NeurologyOphthalmology Rare	5	Phase 2	5
LGVN	Longeveron	CardiovascularMetabolic+1 Rare	4	Phase 2	4
MRKR	Marker Therapeutics	Oncology	4	Phase 1	4
INKT	MiNK Therapeutics	ImmunologyOncology+1 Rare	7	Phase 2	7
NKTX	Nkarta	ImmunologyNeurology+1 Rare	8	Phase 1	8
OCGN	Ocugen	Infectious DiseaseOphthalmology Rare	1	Phase 3	12
DTIL	Precision Biosciences	Infectious DiseaseMetabolic+1 Rare	1	Phase 1	5
TARA	Protara Therapeutics	DermatologyMetabolic+1 Rare	2	Phase 2	3
SANA	Sana Biotechnology	MetabolicOncology	2	Phase 1	4
TGTX	Tg Therapeutics	Neurology Rare	1	Approved	6